Search Results

There are 11931 results for: content related to: Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation

  1. You have free access to this content
    Listeria monocytogenes virulence proteins induce surface expression of Fas ligand on T lymphocytes

    Molecular Microbiology

    Volume 51, Issue 5, March 2004, Pages: 1483–1492, Lauren A. Zenewicz, Jason A. Skinner, Howard Goldfine and Hao Shen

    Article first published online : 4 FEB 2004, DOI: 10.1111/j.1365-2958.2003.03931.x

  2. You have free access to this content
    A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells

    FEBS Letters

    Volume 581, Issue 23, September 18, 2007, Pages: 4455–4462, Peter B. Thornhill, Jason B. Cohn, Gillian Drury, William L. Stanford, Alan Bernstein and Julie Desbarats

    Article first published online : 22 AUG 2007, DOI: 10.1016/j.febslet.2007.08.025

  3. miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia


    Volume 60, Issue 12, December 2012, Pages: 1888–1895, Li Zhang, Lian-Yan Dong, Ya-Jian Li, Zhen Hong and Wen-Shi Wei

    Article first published online : 20 AUG 2012, DOI: 10.1002/glia.22404

  4. A vision of cell death: Fas ligand and immune privilege 10 years later

    Immunological Reviews

    Volume 213, Issue 1, October 2006, Pages: 228–238, Thomas A. Ferguson and Thomas S. Griffith

    Article first published online : 14 SEP 2006, DOI: 10.1111/j.1600-065X.2006.00430.x

  5. Functional arterial spin labeling: Optimal sequence duration for motor activation mapping in clinical practice

    Journal of Magnetic Resonance Imaging

    Volume 36, Issue 6, December 2012, Pages: 1435–1444, Hélène Raoult, Jean–Christophe Ferré, Jan Petr, Elise Bannier, Aymeric Stamm, Christian Barillot and Jean-Yves Gauvrit

    Article first published online : 24 AUG 2012, DOI: 10.1002/jmri.23782

  6. You have free access to this content
    Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus

    Clinical & Experimental Immunology

    Volume 129, Issue 2, August 2002, Pages: 359–369, S. MIHARA, N. SUZUKI, Y. TAKEBA, K. SOEJIMA and S. YAMAMOTO

    Article first published online : 5 AUG 2002, DOI: 10.1046/j.1365-2249.2002.01812.x

  7. You have free access to this content
    The regulation of FasL expression during activation-induced cell death (AICD)


    Volume 103, Issue 4, August 2001, Pages: 426–434, Thang Nguyen and John Russell

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1365-2567.2001.01264.x

  8. You have free access to this content
    Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance


    Volume 22, Issue 6, November 2004, Pages: 908–924, Osnat Bohana-Kashtan and Curt I. Civin

    Article first published online : 1 NOV 2004, DOI: 10.1634/stemcells.22-6-908

  9. Clinicopathologic Analysis of Fas, Fas Ligand, and Other Biomarkers in Locally Advanced Breast Carcinoma

    The Breast Journal

    Volume 6, Issue 4, July 2000, Pages: 233–241, Nat L. Pernick, Laura Biernat, Wei Du and Daniel W. Visscher

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1524-4741.2000.98087.x

  10. You have free access to this content
    Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentation

    FEBS Letters

    Volume 580, Issue 2, January 23, 2006, Pages: 443–449, Shijun Kang, Rongcheng Luo, Yoel Smicun, David A. Fishman and Yuru Meng

    Article first published online : 20 DEC 2005, DOI: 10.1016/j.febslet.2005.12.033

  11. FasL-triggered death of Jurkat cells requires caspase 8-induced, ATP-dependent cross-talk between fas and the purinergic receptor P2X7

    Journal of Cellular Physiology

    Volume 228, Issue 2, February 2013, Pages: 485–493, Adam Aguirre, Kenji F. Shoji, Juan C. Sáez, Mauricio Henríquez and Andrew FG Quest

    Article first published online : 25 OCT 2012, DOI: 10.1002/jcp.24159

  12. You have free access to this content
    ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis

    Journal of Bone and Mineral Research

    Volume 28, Issue 2, February 2013, Pages: 283–290, Alejandro J Garcia, Colton Tom, Miriam Guemes, Gloria Polanco, Maria E Mayorga, Korinna Wend, Gustavo A Miranda-Carboni and Susan A Krum

    Article first published online : 15 JAN 2013, DOI: 10.1002/jbmr.1747

  13. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status

    The Journal of Pathology

    Volume 201, Issue 1, September 2003, Pages: 46–54, Julie M Michael-Robinson, Nirmala Pandeya, Margaret C Cummings, Michael D Walsh, Joanne P Young, Barbara A Leggett, David M Purdie, Jeremy R Jass and Graham L Radford-Smith

    Article first published online : 30 MAY 2003, DOI: 10.1002/path.1406

  14. You have free access to this content
    Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells

    Journal of Orthopaedic Research

    Volume 31, Issue 4, April 2013, Pages: 608–615, Junya Yamamoto, Koichiro Maeno, Toru Takada, Kenichiro Kakutani, Takashi Yurube, Zhongying Zhang, Hiroaki Hirata, Takuto Kurakawa, Daisuke Sakai, Joji Mochida, Minoru Doita, Masahiro Kurosaka and Kotaro Nishida

    Article first published online : 28 NOV 2012, DOI: 10.1002/jor.22274

  15. You have free access to this content
    Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: Heparin prevents and treats liver damage


    Volume 53, Issue 4, April 2011, Pages: 1323–1332, Sujith V. W. Weerasinghe, David S. Moons, Peter J. Altshuler, Yatrik M. Shah and M. Bishr Omary

    Article first published online : 7 APR 2011, DOI: 10.1002/hep.24203

  16. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity


    Volume 11, Issue 1, January 2004, Pages: 43–52, Ulrike B. Matter-Reissmann, Kai-Christian Sonntag, Urs O. Gilli, Christian Leguern, Mårten K. J. Schneider and Jörg D. Seebach

    Article first published online : 16 DEC 2003, DOI: 10.1111/j.1399-3089.2004.00081.x

  17. You have free access to this content
    Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells

    European Journal of Biochemistry

    Volume 269, Issue 4, February 2002, Pages: 1162–1170, Mi-Ock Lee, Hyo-Jin Kang, Young Mi Kim, Ji-Hyun Oum and Jungchan Park

    Article first published online : 20 FEB 2002, DOI: 10.1046/j.1432-1033.2002.02748.x

  18. You have free access to this content
    Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells


    Volume 105, Issue 3, March 2002, Pages: 267–277, Jie-Hui Li, Dalia Rosen, Paul Sondel and Gideon Berke

    Article first published online : 25 MAR 2002, DOI: 10.1046/j.1365-2567.2002.01380.x

  19. You have free access to this content
    α-Fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases

    European Journal of Biochemistry

    Volume 266, Issue 3, December (II) 1999, Pages: 750–761, Elena Dudich, Lidia Semenkova, Igor Dudich, Elena Gorbatova, Natasha Tochtamisheva, Edward Tatulov, Marina Nikolaeva and Gennady Sukhikh

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00868.x

  20. You have free access to this content
    Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production

    The FEBS Journal

    Volume 274, Issue 9, May 2007, Pages: 2376–2384, Norihiko Matsumoto, Ryu Imamura and Takashi Suda

    Article first published online : 2 APR 2007, DOI: 10.1111/j.1742-4658.2007.05772.x